Back to Market Feed

This NDC is on FDA's drug shortage list (posted Oct 12, 2022)

Reported reason: Shortage of an active ingredient

Product Information

DEXTROAMP-AMPHETAM 12.5 MG TAB is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.3592 per EA under NDC 70010011401. Its NADAC has been published 20 times since Aug 9, 2023.

FDA first approved this application on Dec 28, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1

NDC

70010011401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215771

FDA Approved

12/28/2021

TE Code

AB

On Market Since

3/28/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has been published 20 times since Aug 9, 2023, and over the history we have for it it has declined 41.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3592 per EA
All-time high$0.6121 (Aug 16, 2023)
All-time low$0.3445 (Aug 26, 2026)
52-week high$0.3592
52-week low$0.3445
Median price$0.5271
Average price$0.4833
Largest weekly change-34.0% (Aug 26, 2026)
Weeks tracked20
Tracking sinceAug 9, 2023

Price History

1W

0.0%

1M

+4.3%

3M

-31.2%

6M

-31.2%

1Y

-31.2%

3Y

-32.5%

5Y

N/A

All

-41.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

3 alternatives • Same active ingredient

DEXTROAMP-AMPHETAM 12.5 MG TAB
Generic
64850050301•Elite Laboratories, Inc.
$0.3592
DEXTROAMP-AMPHETAM 12.5 MG TAB
Generic
00527076337•Lannett Company Inc.
$0.3592
DEXTROAMP-AMPHETAM 12.5 MG TAB
Generic
00555077602•Teva Pharmaceuticals USA Inc.
$0.3592

Related Drugs

Same classification

BACK-BODY PAIN 500-32.5 MG CPLT
Generic
70000012702•Cardinal Health
$0.0422
per EA
EXTRA PAIN RELIEF CAPLET
Generic
49483037000•Time-Cap Labs Inc.
$0.0621
per EA
TENSION HEADACHE CAPLET
Generic
70000015901•Cardinal Health
$0.0622
per EA
TENSION HEADACHE CAPLET
Generic
70000015902•Cardinal Health
$0.0622
per EA
QC HEADACHE RELIEF TABLET
Generic
63868048501•Chain Drug Marketing Association
$0.0629
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037462•L. Perrigo Company
$0.0648
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037478•L. Perrigo Company
$0.0648
per EA
PAIN RELIEVER PLS 250-250-65 MG
Generic
00536132601•Rugby Laboratories
$0.0648
per EA
MIGRAINE 250-250-65 MG CPLT
Generic
24385036571•AmerisourceBergen
$0.0648
per EA
MIGRAINE FORMULA CAPLET
Generic
24385036578•AmerisourceBergen
$0.0648
per EA

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Manufacturer

Granules Pharmaceuticals Inc. manufacturer profile

See the full portfolio, pricing trend, and other products from this labeler.

Drug market

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate market comparison

Compare this molecule across participating manufacturers and inspect the broader market price spread.

Therapeutic class

Central Nervous System Stimulant class view

See how this drug behaves alongside other products in the same FDA pharmacologic class.

Trend hub

Latest market trends

Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.

Guide

Understanding NADAC pricing

Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAM 12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 12.5 MG TAB, manufactured by Granules Pharmaceuticals Inc., is $0.3592 per EA (NDC 70010011401), effective Sep 30, 2026.

How has the price of DEXTROAMP-AMPHETAM 12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has declined 41.3%. It has been tracked across 20 weekly CMS publications since Aug 9, 2023.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 12.5 MG TAB?

Since Aug 9, 2023, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has ranged from a low of $0.3445 (Aug 26, 2026) to a high of $0.6121 (Aug 16, 2023), with a median of $0.5271 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAM 12.5 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAM 12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAM 12.5 MG TAB?

DEXTROAMP-AMPHETAM 12.5 MG TAB (NDC 70010011401) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.

Is DEXTROAMP-AMPHETAM 12.5 MG TAB in shortage?

Yes — NDC 70010011401 is currently listed in FDA's drug shortage database (posted Oct 12, 2022). Reported reason: Shortage of an active ingredient.